In general, endothelial CD147 deficiency reduces the expression of core AD genes, including App, Psen2, and Ifitm3, and we hypothesize that CD147 is a promising risk factor for AD and other neurodegenerative diseases. The gene discussed is APP; the disease is neurodegenerative disease.